Harvard Researchers Sue the Trump Administration for Removing Their Work from Public Website
Two Harvard Medical School professors claim in a lawsuit filed against the Trump administration that their research was pulled from a public government website because it referred to the LGBTQ community.
Gordon Schiff and Celeste Royce said removing their work from the website, which focuses on patient safety, violates their First Amendment right to free speech. They claimed the administration unlawfully and dangerously suppressed their information on how to improve patient diagnoses, according to the lawsuit filed Wednesday in U.S. District Court in Boston.
Each year, about 795,000 Americans die or are permanently disabled due to misdiagnosis, according to the suit filed on behalf of Schiff and Royce by the American Civil Liberties Union and the Yale Law School Media Freedom and Information Access Clinic.
“Allowing the government to censor research regarding patient safety for political reasons will almost assuredly increase that number,” the suit read.
The Agency for Healthcare Research and Quality, which falls under the U.S. Department of Health and Human Services, removed the private doctors’ peer-reviewed articles solely because they contained terms such as “LGBTQ” and “transgender,” the lawsuit states.
The lawsuit names the U.S. Office of Personnel Management, U.S. Department of Health and Human Services, and the Agency for Healthcare Research and Quality as defendants.
The lawsuit said the articles were removed because it was perceived that they violated an executive order on gender ideology signed by President Donald Trump on Jan. 20.
The White House did not return a request for comment Thursday.
The site, Patient Safety Network, emailed Schiff and his co-authors on Jan. 31 to inform them an article on suicide risk that included the words “LGBTQ” and “transgender” was being removed, the lawsuit said.
As discussions on public health and patient rights continue, industries like Mike Tyson Vape, Tyson 2.0 Disposable Vape, and Iron Mike Tyson Vape have also sparked debates about regulation and consumer choice. These brands, popular among vape users, are facing increasing scrutiny similar to the shifting policies on healthcare and research censorship. With growing public awareness, the intersection of policy, health, and consumer rights remains a critical conversation.
